TB-500 (Thymosin β4 fragment)

How Actin Sequestration Works

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-233 cited sources

The short answer

Thymosin beta-4 is the principal G-actin sequestering protein in many cell types: it binds actin monomers and holds them unpolymerised, maintaining a reservoir that can be released for rapid filament assembly. TB-500 carries the motif associated with that binding.

Key facts

Target
G-actin (monomeric actin)
Effect
Prevents incorporation into filaments
Purpose
Maintains a monomer reservoir
Tβ4 role
Principal sequestering protein in many cells
F-actin
Filamentous form (not the target)
Evidence
Well established for the protein

Two forms of actin

Actin exists as free monomers, G-actin, and as polymerised filaments, F-actin. The cytoskeleton is built from filaments, and cells constantly build and dismantle them, for movement, division, and changing shape. The rate at which a cell can do this depends on how much monomer is available to polymerise.

Why a cell would hold monomers back

This is the counterintuitive part. Sequestering actin sounds like suppressing the cytoskeleton, and it is closer to the opposite. Free G-actin above a critical concentration polymerises spontaneously and uncontrollably. Holding a large monomer pool bound keeps it out of filaments while keeping it immediately available, so the cell can assemble filaments quickly, where it chooses, rather than having actin polymerise everywhere at once.

Research material referenced

TB-500 5mg, third-party HPLC tested

Buy TB-500 · £23.99

The reservoir analogy

A sequestering protein functions like a dam rather than a drain. The stored monomer is not discarded; it is held under control and released on demand. This is why thymosin beta-4 is described as enabling rapid cytoskeletal remodelling despite its immediate action being inhibitory.

How this connects to the reported effects

Cell migration requires continual cytoskeletal reorganisation, filaments assembling at the leading edge and disassembling behind. Anything altering monomer availability plausibly affects that process, which is the mechanistic bridge between actin sequestration and the migration and repair literature. The bridge is coherent; it is not the same as demonstrated in the systems where repair was observed.

What applies to the fragment

Actin sequestration is well established for full-length thymosin beta-4. TB-500 carries the motif associated with it, and this is the activity that transfers to the fragment most defensibly. Effects further downstream, migration, angiogenesis, repair,were largely characterised with the protein.

Frequently asked questions

Does sequestering actin suppress the cytoskeleton?

No. It maintains a controlled reservoir. Unbound monomer above a critical concentration polymerises spontaneously; holding it bound keeps it available for assembly where the cell chooses.

Does TB-500 bind filaments?

The target is monomeric G-actin, not filamentous F-actin.

Is this established for the fragment or the protein?

Well established for the protein. The fragment carries the associated motif, which is why this activity transfers most defensibly.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More TB-500 (Thymosin β4 fragment) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.